A multicenter randomized double-blind trial comparing rosiglitazone to placebo for the prevention of atherosclerosis progression after coronary bypass surgery in diabetic patients

Trial Profile

A multicenter randomized double-blind trial comparing rosiglitazone to placebo for the prevention of atherosclerosis progression after coronary bypass surgery in diabetic patients

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 01 Sep 2009

At a glance

  • Drugs Rosiglitazone (Primary)
  • Indications Atherosclerosis; Coronary artery disease; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms VICTORY
  • Most Recent Events

    • 01 Sep 2009 Design and trial rationale published in the Canadian Journal of Cardiology.
    • 29 Apr 2008 Results presented at ACC 2008
    • 26 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top